Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Supernus Pharmaceuticals Beats Third-Quarter Sales, Earnings Views ...
A logo sign outside of the headquarters of Supernus Pharmaceuticals in ...
Supernus Pharmaceuticals | Rockville, MD | Life Science Construction ...
Supernus Pharmaceuticals to Participate in the Bank of America 2026 ...
Supernus Pharmaceuticals logo in transparent PNG format
A logo sign outside of the headquarters of Supernus Pharmaceuticals ...
Supernus hi-res stock photography and images - Alamy
Supernus Pharmaceuticals - Jorg9
Supernus Pharmaceuticals Q4 Earnings Call Highlights
Employees Embrace Better ITSM at Supernus Pharmaceuticals
Supernus Pharmaceuticals Reviews: Pros And Cons of Working At Supernus ...
Rockville’s Supernus Pharmaceuticals Secures $150 Million Loan - The ...
In this photo illustration, the Supernus Pharmaceuticals logo is ...
Supernus Pharmaceuticals, Inc. on LinkedIn: Sneak peek behind the ...
Supernus Pharmaceuticals Q1 2025: Navigating Growth Amid Generic Headwinds
Supernus Pharmaceuticals picks up embattled Sage Therapeutics ...
Supernus Enters Into $150 Million Credit Facility | citybiz
© 2025 Supernus Pharmaceuticals, Inc. All Rights Reserved. Four Growth ...
Supernus Pharmaceuticals | The Org
New Supernus Pharmaceuticals Headquarters and Laboratories ...
Working at Supernus Pharmaceuticals | Glassdoor
Supernus compra Sage por 485,21 millones de euros para impulsar el ...
Supernus Pharmaceuticals Acquires NV-5138 Assets from Navitor ...
FDA Approval For Parkinson's Treatment: U.S. FDA approves Supernus ...
Supernus buys Sage Therapeutics, boosting neuropsychiatry pipeline ...
Supernus Pharmaceuticals
Supernus Pharmaceuticals Reports Q2 2025 Revenue of $165.5 Million ...
Supernus Pharmaceuticals announces acquisition of US WorldMeds
August 12, 2019, Brazil: In this photo illustration the Supernus ...
Supernus Pharmaceuticals (SUPN) Earnings Date and Reports 2026
Supernus Pharmaceuticals, Inc. on LinkedIn: #atmrd2023 #pdcommunity # ...
Supernus Pharmaceuticals (SUPN): A Hidden Gem in the Market? A ...
Supernus Pharmaceuticals Announces FDA Approval for Updated Qelbree ...
SUPN | Supernus Pharmaceuticals, Inc. Stock Data, Price & News
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics ...
#mdscongress #parkinsons #teamsupernus | Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals - Corporate Overview May 2021
Supernus Pharmaceuticals 2026 Company Profile: Stock Performance ...
Supernus Pharmaceuticals, Inc. on LinkedIn: #cns
7 Supernus Pharmaceuticals Royalty-Free Images, Stock Photos & Pictures ...
Supernus Pharmaceuticals to Participate in the TD Cowen 4th | Lifecarenews
Supernus Pharmaceuticals to present at 2025 CNS virtual conference ...
Supernus Maintains Full-Year Outlook Amid Ongoing Losses - Stocks Today
Supernus Pharmaceuticals: A CNS Therapeutics Powerhouse with Strong ...
FDA issues second CRL to Supernus for Parkinson’s drug-device combo ...
If You Invested $1,000 in Supernus Pharma (SUPN) | Stock Titan
Supernus Pharmaceuticals - Abingworth - Abingworth LLP
Supernus Openings
Supernus Pharmaceuticals self-medicates with Freshworks for IT support
I am thrilled to announce that I have joined Supernus Pharmaceuticals ...
Supernus logo hi-res stock photography and images - Alamy
#apsard2024 #adhd | Supernus Pharmaceuticals, Inc.
PharmaShots on LinkedIn: Supernus Reports the US FDA’s Acceptance to ...
© 2025 Supernus Pharmaceuticals, Inc. All Rights Reserved. Q&A 13
3 Supernus Pharmaceuticals Images, Stock Photos, 3D objects, & Vectors ...
Supernus Pharmaceuticals, Inc. on LinkedIn: Supernus Pharmaceuticals ...
Supernus Pharmaceuticals (SUPN) Investor Presentation - Slideshow ...
HSAPAY on LinkedIn: Supernus Pharmaceuticals' CEO Jack Khattar to Speak ...
SUPN - Supernus Pharmaceuticals | KPIs | Fundamentei
SUPN SEC Filings - SUPERNUS PHARMACEUTICALS, INC. 10-K, 10-Q, 8-K Forms
Supernus Pharmaceuticals Strategy and Business Model
Supernus Pharmaceuticals Stock Gains Following Drug Study Data
Supernus Pharmaceuticals to Acquire Sage Therapeutics,
Supernus expands CNS portfolio with buy of Adamas Pharma | The Pharmaletter
Supernus Pharmaceuticals to Acquire Sage Therapeutics for $561 Million ...
Supernus Pharmaceuticals Stock Falls As Trokendi Sales Lag
Supernus Pharmaceuticals (NASDAQ:SUPN) Beats Expectations in Strong Q2 ...
Supernus Stock Reverses Downward Despite Good ADHD Drug Trial | Stock ...
Supernus Pharmaceuticals Inc (SUPN) Q2 2025 Earnings Call Highlights ...
#teamsupernus | Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals Culture | Comparably
Supernus Pharmaceuticals, Inc. on LinkedIn: #adhd #aanp2024 # ...
Supernus Pharmaceuticals Advances with RENAISSANCE 2 Study on SPN-817 ...
Supernus Pharmaceuticals to acquire Sage Therapeutics for $561M ...
#parkinsonsdisease #pd | Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals logo in transparent PNG and vectorized SVG formats
Supernus Pharmaceuticals - The Parkinson's Expo
Supernus Pharmaceuticals Q1 Earnings: Revenue Beats Estimates Amid ...
近十年首批！FDA批准Supernus過動症創新非中樞神經刺激劑療法-環球生技月刊
甲磺酸沙非胺(Safinamide mesylate) - 药物靶点：MAO-B_在研适应症：帕金森病_专利_临床_研发
In this photo illustration, a person is holding a mobile phone with the ...
Corporate Membership - National Association of Nurse Practitioners in ...
過動症福音！Supernus Pharmaceuticals新藥三期臨床成果積極-環球生技月刊
This Top-Rated Biotech Just Popped To A Record High On An Upgrade ...
从巨头剥离20载，Supernus掀起CNS狂潮：提交新药申请，用于治疗PD_摩熵医药(原药融云)
I am extremely happy to announce I have accepted a full time offer from ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's ...
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded ...
FDA approval of update to the label of Qelbree (viloxazine extended ...
Arthrosi drug trial in gout delivers for new owner Sobi | pharmaphorum
Parkinson's Care Partner Education Program - Parkinson's Association of ...
Partnerships | PMD Alliance
